Pharmaceutical / Drug Definition :
Thought to act by specific, reversible inhibition of immunocompetent lymphocytes in G0-G1 phase of cell cycle. Preferentially inhibits T lymphocytes; also inhibits lymphokine production. Ophthalmic action is unknown.
FDA Label Requirements and Exceptions
FDA Import Information
Cyclosporine (Cyclosporine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Cyclosporine (Cyclosporine Suppliers)
- Processors Cyclosporine
- Repackers Cyclosporine
- Relabelers Cyclosporine
- Exporters Cyclosporine
- Importers Cyclosporine
For more information about Cyclosporine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.